Axios
US · 58 mins ago
✦ 75◉ Centre
Makary's exit creates new uncertainty at FDA
75Credibility
0Ratings
0Comments
AI Analysis
Credibility 75/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Marty Makary's departure from the FDA may reduce controversy but leaves unresolved organizational problems, while the Senate faces challenges confirming a new commissioner alongside other health agency nominations.
Makary's exit creates new uncertainty at FDA
Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy.
But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure.
Why it matters: There's lots of uncertainty around how the Senate will find the bandwidth to confirm another FDA commissioner while it considers President Trump's nominees for Centers for Disease Control and Prevention director and surgeon genera
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!